idarubicin has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koning, GA; Lokerse, WJM; Lu, T; Seynhaeve, ALB; Ten Hagen, TLM | 1 |
1 other study(ies) available for idarubicin and B16 Melanoma
Article | Year |
---|---|
Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Dose-Response Relationship, Drug; Doxorubicin; Drug Compounding; Drug Stability; Humans; Hydrogen-Ion Concentration; Hyperthermia, Induced; Idarubicin; Kinetics; Lipids; Liposomes; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Nude; Polyethylene Glycols; Skin Neoplasms; Solubility; Temperature; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |